Regular contributor Brendan Shaw* casts his eye over the recently announced 2023 WHO Essential Medicines List, how it reflects growing pharmaceutical…

Antimicrobial resistance (AMR), or the resistance of pathogens to antibiotics, antivirals, antifungals and antiparasitics has been declared by the…

Representatives from the US FDA, EMA, WHO and the pharma industry debated over the possible inclusion of environmental impact in future good…

The World Health Assembly Special Session on a Pandemic Treaty, which will convene health ministries from around the world in Geneva next week, offers…

In a notable first, following successful pilot immunisation programmes in Ghana, Kenya and Malawi, the World Health Organization (WHO) has recommended…

Shawview Consulting's Brendan Shaw examines the WHO's recently released updated Essential Medicines List. Shaw highlights some of the key trends and…

The global rush to secure access to COVID-19 vaccines has led to accusations that richer countries are hoarding supply at the expense of poorer…

László Dene, managing director of Bellis, gives his insights on the trends affecting the wholesale supply chain and product delivery in Hungary, the…

Dr Antal Feller, CEO of Hungaropharma, gives his insights on the pharma trends affecting the wholesale supply chain and product delivery in Hungary,…

Tomáš Votruba of the Association of Full-Line Wholesalers (AVEL), which gathers the three major players of the pharmaceutical distribution market…

The WHO has published its most recent edition of the Essential Medicines List in July 2019. On the list are 28 new medicines for adults, making a…

Brendan Shaw, Principal of Shawview Consulting and Adjunct Senior Lecturer at the University of New South Wales, shares highlights from the 2019 World…